🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

83 results for “Pasteur” Clear

  1. Placebo

    Sanofi Pasteur

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  2. Placebo

    Sanofi Pasteur

    Colorectal Neoplasms

    phase 3 small molecule completed

    1 trial

  3. Rimonabant

    Sanofi Pasteur

    Obesity

    phase 3 small molecule terminated

    1 trial

  4. SR34006 (idraparinux sodium) Injection

    Sanofi Pasteur

    Pulmonary Embolism

    phase 3 small molecule completed

    1 trial

  5. Sarilumab

    Sanofi Pasteur

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial

  6. Semuloparin sodium

    Sanofi Pasteur

    Venous Thromboembolism

    phase 3 small molecule terminated

    1 trial

  7. Teplizumab

    Sanofi Pasteur

    Type 1 Diabetes Mellitus

    phase 3 small molecule active

    1 trial

  8. Tolebrutinib

    Sanofi Pasteur

    Non-relapsing Secondary Progressive Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  9. Vandetanib

    Sanofi Pasteur

    Locally Advanced or Metastatic Medullary Thyroid Cancer

    phase 3 small molecule completed

    1 trial

  10. Vandetanib

    Sanofi Pasteur

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  11. Venglustat GZ402671

    Sanofi Pasteur

    Congenital Cystic Kidney Disease

    phase 3 small molecule terminated

    1 trial

  12. ZD6474 (vandetanib)

    Sanofi Pasteur

    Non-Small-Cell Lung Carcinoma

    phase 3 small molecule completed

    1 trial

  13. afuzosin

    Sanofi Pasteur

    Benign Prostatic Hyperplasia

    phase 3 small molecule completed

    1 trial

  14. fexofenadine HCL (M016455)

    Sanofi Pasteur

    Rhinitis Seasonal

    phase 3 small molecule completed

    1 trial

  15. fitusiran

    Sanofi Pasteur

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  16. hydroxychloroquine (Z0188)

    Sanofi Pasteur

    Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

    phase 3 small molecule completed

    1 trial

  17. lixisenatide AVE0010

    Sanofi Pasteur

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  18. placebo (saline)

    Sanofi Pasteur

    Sphingomyelin Lipidosis

    phase 3 small molecule completed

    1 trial

  19. ALX-0061

    Sanofi Pasteur

    Lupus Erythematosus, Systemic

    phase 2 mab completed

    1 trial

  20. Advate (Low Dose)

    Sanofi Pasteur

    Hemophilia A

    phase 2 mab completed

    1 trial

  21. Amcenestrant

    Sanofi Pasteur

    Breast Cancer Metastatic

    phase 2 small molecule terminated

    1 trial

  22. Enteric coated sevelamer

    Sanofi Pasteur

    Hypercholesterolemia

    phase 2 small molecule completed

    1 trial

  23. Ferroquine SSR97193

    Sanofi Pasteur

    Plasmodium Falciparum Infection

    phase 2 small molecule terminated

    1 trial

  24. HP184

    Sanofi Pasteur

    Spinal Cord Injury

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources